Adverse Outcomes and Mortality in Liver Transplant (NCT05477277)

🧪 Interventions in This Study

• MAsS (DIAGNOSTIC_TEST)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Mayo Clinic Arizona — Phoenix, Arizona

📞 Contact the Study Coordinator

Phone: (480) 342-5756

Email: bunkley.latasha@mayo.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in End Stage Liver DIsease

• Disparities Among Liver Transplant Patients — Phoenix, Arizona
• Tocotrienol Against the Progression of End Stage Liver Disease — Indianapolis, Indiana
• Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes — Boston, Massachusetts
• Functional Assessment in Liver Transplantation — Little Rock, Arkansas

Explore by condition: All End Stage Liver DIsease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.